Innovative Biochips is a spin-off company from Houston Texas Medical Center (TMC), a rich environment that places unique assets and a wealth of resources at the disposal of all investigators and researchers in life science field.
Innovative Biochips is committed to develop advanced microfluidic technologies that resolve traditional biotech challenges by achieving cutting-edge sensitivity and high-throughput. The company’s scientists and engineers have extensive and successful experience in developing novel microfluidic technologies for various biological and biomedical applications.
Innovative Biochips has currently 18 international distributors in Europe and Asia, and has engaged Fisher Scientific to sell its products in USA. Moreover, Innovative Biochips has established business collaboration with Thermo Fisher Scientific, Millipore Sigma, BioTek, and Harvard Bioscience that allows key benefits to drive product development.
via membrane deformation
aging using a microfluidic system